MRNA

Vaxess announces $9 million in funding for mRNA vaccine patch
Vaxess announces $9 million in funding for mRNA vaccine patch
Biopharma Reporter
Vaxess Technologies
vaccine patches
funding
MRNA
vaccines
Flag link:
Moderna aims for the stars again with ambitious drug development plan
Moderna aims for the stars again with ambitious drug development plan
BioPharma Dive
Moderna Therapeutics
drug development
MRNA
Flag link:
After AstraZeneca mRNA deal, CanSino eyes other production partnerships
After AstraZeneca mRNA deal, CanSino eyes other production partnerships
Fierce Pharma
CanSino
MRNA
AstraZeneca
vaccines
Flag link:
Pfizer, BioNTech seek administrative review of 2 Moderna patents at heart of mRNA vaccine litigation
Pfizer, BioNTech seek administrative review of 2 Moderna patents at heart of mRNA vaccine litigation
Fierce Pharma
Pfizer
BioNTech
Moderna Therapeutics
vaccines
MRNA
COVID-19
patents
Flag link:
Moderna, CARsgen Join Forces Combining mRNA Cancer Vaccine with CAR T
Moderna, CARsgen Join Forces Combining mRNA Cancer Vaccine with CAR T
BioSpace
Moderna Therapeutics
CARsgen
MRNA
cancer
cancer vaccine
vaccines
solid tumors
CAR-T
Flag link:
Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans
Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans
Fierce Biotech
Moderna Therapeutics
Claudin18.2
MRNA
vaccines
CAR-T
cancer vaccine
solid tumors
Flag link:
Riding the mRNA wave, HDT Bio closes in on cancer-fighting vaccine
Riding the mRNA wave, HDT Bio closes in on cancer-fighting vaccine
Pharma Voice
HDT Bio
MRNA
vaccines
cancer
cancer vaccines
Steve Reed
Flag link:
Sanofi, BioNTech cull mRNA clinical cytokine cancer candidate based on early data
Sanofi, BioNTech cull mRNA clinical cytokine cancer candidate based on early data
Fierce Biotech
Sanofi
BioNTech
MRNA
cytokines
cancer
Flag link:
Moderna/Merck begins late-stage study of skin cancer vaccine combination
Moderna/Merck begins late-stage study of skin cancer vaccine combination
Yahoo/Reuters
Moderna Therapeutics
Merck
MRNA
vaccines
skin cancer
Keytruda
clinical trials
Flag link:
MIT researchers to lead a new center for continuous mRNA manufacturing
MIT researchers to lead a new center for continuous mRNA manufacturing
MIT News
MIT
FDA
MRNA
Flag link:
Moderna strikes deal to develop mRNA drugs in China
Moderna strikes deal to develop mRNA drugs in China
Financial Times
Moderna Therapeutics
China
MRNA
Flag link:
Sanofi says it's back to the drawing board on mRNA flu vaccines
Sanofi says it's back to the drawing board on mRNA flu vaccines
Reuters
Sanofi
vaccines
MRNA
flu vaccines
Flu
Flag link:
Cartesian maps the path for an autoimmune disease cell therapy
Cartesian maps the path for an autoimmune disease cell therapy
EP Vantage
Cartesian Therapeutics
MRNA
CAR-T
autoimmune disease
Flag link:
Gritstone bio supports mRNA Covid-19 vaccine plans with Phase I publication
Gritstone bio supports mRNA Covid-19 vaccine plans with Phase I publication
Clinical Trials Arena
Gritstone Bio
clinical trials
MRNA
samRNA
vaccines
COVID-19
Flag link:
Moderna, Pfizer Hit with New COVID Vaccine Patent Lawsuits
Moderna, Pfizer Hit with New COVID Vaccine Patent Lawsuits
BioSpace
Moderna
Pfizer
patents
MRNA
Promosome
legal
COVID-19
vaccines
Flag link:
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
Yahoo/Reuters
ASCO 2023
Merck
Moderna Therapeutics
MRNA
vaccines
skin cancer
Flag link:
Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Biopharma Reporter
vaccines
MRNA
Merck
Asia-Pacific
Flag link:
Moderna, looking beyond vaccines, guides first mRNA protein replacement therapy past early clinical test
Moderna, looking beyond vaccines, guides first mRNA protein replacement therapy past early clinical test
Fierce Biotech
Moderna Therapeutics
MRNA
intracellular proteins
clinical trials
propionic acidemia
Flag link:
Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline
Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline
PR Newswire
Myeloid Therapeutics
funding
MRNA
immunotherapy
Flag link:
Clinical Trial of mRNA Universal Influenza Vaccine Candidate Begins
Clinical Trial of mRNA Universal Influenza Vaccine Candidate Begins
Drugs.com
universal flu vaccine
clinical trials
NIAID
MRNA
vaccines
Flag link:

Pages